The project involves the implementation of a prophylaxis progr for diseases adversely affecting the labour resources of the working population.The project’s aim is to increase the number of people K and M at the working age who have reached 18 years of PCI type B and C sent for treatment in drug thresholds, as well as to increase awareness of the incidence of HBV and HCV infections.The project assumes the implementation of the tasks of the prophylaxis.and activities related to the education of patients undergoing medical treatment in bad screening in Małopolskie, Swietokrzyskie, Podkarpackie province in the period 01.02.2020 to 30.06.2023. Trained POZ doctors will be selecting people who are eligible for the Project among patients. These people will have an interview (with a checklist) and filling in program docks. The materials will be prepared by MC.The element of the kwalif. visit is a rapid test (RDT) for HBV and HCV in people at risk. The patient receives the result of the test during the qualifi visit. If it is negatowas infor materials with recommendations to reduce the risk of HBV/HCV infection. If positive- patients are headed to bad.lab. (blood donation). The final visit includes patients who have taken blood samples. In the case of confirmation of the diagnosis of hepatitis, the medicinal product shall be provided with a package leaflet for patients with a confirmed hepatitis. If a PMI is confirmed (positive HBsAg score) or PCI (positive HCV-RNA score), the medicine directs the patient to the SU for further examinations confirming the diagnosis of PCIs and qualification for the appropriate drug program. The patient receives information about the Patient Coordinator and contact details. In the event of a negative result, the patient receives a package leaflet to promote it. minimise the risk of HCV/HBV infection.After completing the path of the support provided in the Programme, patients fill in a satisfaction survey (either at the POZ stage, or directed to drug programs in the SU).